Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Depreciation and Depletion (2016 - 2026)

Catalyst Pharmaceuticals filings provide 16 years of Depreciation and Depletion readings, the most recent being $70000.0 for Q1 2026.

  • On a quarterly basis, Depreciation and Depletion fell 39.13% to $70000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $330000.0, a 22.54% decrease, with the full-year FY2025 number at $375000.0, down 5.54% from a year prior.
  • Depreciation and Depletion hit $70000.0 in Q1 2026 for Catalyst Pharmaceuticals, down from $72000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $116000.0 in Q2 2025 to a low of $34000.0 in Q1 2022.
  • Median Depreciation and Depletion over the past 5 years was $81000.0 (2023), compared with a mean of $76411.8.
  • Biggest five-year swings in Depreciation and Depletion: tumbled 64.95% in 2022 and later soared 140.0% in 2023.
  • Catalyst Pharmaceuticals' Depreciation and Depletion stood at $35000.0 in 2022, then soared by 140.0% to $84000.0 in 2023, then soared by 35.71% to $114000.0 in 2024, then tumbled by 36.84% to $72000.0 in 2025, then fell by 2.78% to $70000.0 in 2026.
  • The last three reported values for Depreciation and Depletion were $70000.0 (Q1 2026), $72000.0 (Q4 2025), and $72000.0 (Q3 2025) per Business Quant data.